EP4062913
SOLID ORAL FORMULATION OF UTIDELONE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.9.2021EP published:
8.5.2024EP application number:
21863656.1
EPO information:
European Patent Register
Max expiry date:
1.9.2041
Title in English:
SOLID ORAL FORMULATION OF UTIDELONELanguage of the patent:
English
Timeline
Today
2.9.2021EP application
8.5.2024EP Publication
Owner
Name:
Beijing Biostar Pharmaceuticals Co., Ltd.Address:
Suite 310, Building 3 No. 88 Kechuang 6th Street, Beijing 101111, CN
Name:
CHENGDU BIOSTAR PHARMACEUTICALS, LTD.Address:
No. 308 Kang Qiang 2nd Road Chengdu High Technology Zone Chengdu, Sichuan 611730, CN
Inventor
Name:
TANG, LiAddress:
Beijing 101111, CN
Name:
ZHANG, ChuanAddress:
Sichuan 611730, CN
Name:
QIU, RongguoAddress:
Beijing 101111, CN
Priority
Number:
202010910072Date:
2.9.2020Country:
CN
Classification
Categories:
A61K 31/427, A61K 9/20, A61K 9/22, A61K 9/50, A61K 47/30, A61P 35/00